← Back to all trials
Not Yet Recruiting
NCT06117709
Integrated Smartphone Technology to Alleviate Malignant Pain (I-STAMP) Testing
Conditions: Advanced Cancer, Pain
Sex: All
Ages: 21 Years – N/A
Healthy volunteers: No
Phase: NA
Enrollment: 73
Sponsor: Dana-Farber Cancer Institute
Location: Dana Farber Cancer Institute Boston Massachusetts
Summary
The purpose of the study is to evaluate if the smartphone app, I-STAMP (Integrated Smartphone Technology to Alleviate Malignant Pain), helps participants with cancer pain manage symptoms and keep track of medications.
Eligibility Criteria
Inclusion Criteria for Participants (Activities 1a, 2a, 3a):
* Age ≥ 21 years
* Current or previous diagnosis of advanced cancer
* Current or previous experience with cancer pain
Exclusion Criteria for Participants (Activities 1a, 2a, 3a):
* Inability to understand, speak, or read English
* Any condition that would impede the patient's ability to complete study procedures such as visual impairment or significant cognitive impairment as determined by the participant's treating provider.
Source: ClinicalTrials.gov (NCT06117709). StuddyBuddy aggregates publicly available trial information.
